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Abstract
IFN-γ is an enigmatic cytokine that shows direct anti-viral effects, confers upregulation of
MHC-II and other components relevant for antigen presentation, and that adjusts the com-
position and balance of complex cytokine responses. It is produced during immune
responses by innate as well as adaptive immune cells and can critically affect the course
and outcome of infectious diseases, autoimmunity, and cancer. To selectively analyze the
function of innate immune cell-derived IFN-γ, we generated conditional IFN-γOFF mice, in
which endogenous IFN-γ expression is disrupted by a loxP flanked gene trap cassette
inserted into the first intron of the IFN-γ gene. IFN-γOFF mice were intercrossed with Ncr1-
Cre or CD4-Cre mice that express Cre mainly in NK cells (IFN-γNcr1-ON mice) or T cells (IFN-
γCD4-ON mice), respectively. Rosa26RFP reporter mice intercrossed with Ncr1-Cre mice
showed selective RFP expression in more than 80% of the NK cells, while upon intercross-
ing with CD4-Cre mice abundant RFP expression was detected in T cells, but also to a
minor extent in other immune cell subsets. Previous studies showed that IFN-γ expression
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is needed to promote survival of vaccinia virus (VACV) infection. Interestingly, during VACV
infection of wild type and IFN-γCD4-ON mice two waves of serum IFN-γ were induced that
peaked on day 1 and day 3/4 after infection. Similarly, VACV infected IFN-γNcr1-ON mice
mounted two waves of IFN-γ responses, of which the first one was moderately and the sec-
ond one profoundly reduced when compared with WT mice. Furthermore, IFN-γNcr1-ON as
well as IFN-γCD4-ON mice survived VACV infection, whereas IFN-γOFF mice did not. As
expected, ex vivo analysis of splenocytes derived from VACV infected IFN-γNcr1-ON mice
showed IFN-γ expression in NK cells, but not T cells, whereas IFN-γOFF mice showed IFN-γ
expression neither in NK cells nor T cells. VACV infected IFN-γNcr1-ON mice mounted normal
cytokine responses, restored neutrophil accumulation, and showed normal myeloid cell dis-
tribution in blood and spleen. Additionally, in these mice normal MHC-II expression was
detected on peripheral macrophages, whereas IFN-γOFF mice did not show MHC-II expres-
sion on such cells. In conclusion, upon VACV infection Ncr1 positive cells including NK cells
mount two waves of early IFN-γ responses that are sufficient to promote the induction of pro-
tective anti-viral immunity.
Author summary
Viral infections induce interferon (IFN) responses that constitute a first line of defense.
Type II IFN (IFN-γ) is required for protection against lethal vaccinia virus (VACV) infec-
tion. To address the cellular origin of protective IFN-γ responses during VACV infection,
we generated IFN-γOFF mice, in which the endogenous IFN-γ gene function can be recon-
stituted in a Cre-dependent manner. IFN-γOFF mice were intercrossed with Ncr1-Cre
mice that express Cre selectively in Ncr1+ innate cell subsests such as NK cells. Surpris-
ingly, VACV infected IFN-γNcr1-ON mice mounted two waves of IFN-γ responses. Recon-
stitution of innate IFN-γ was sufficient to restore cytokine responses that supported
normal myeloid cell distribution and survival upon VACV infection. In conclusion, IFN-
γ derived from Ncr1+ innate immune cells is sufficient to elicit fully effective immune
responses upon VACV infection. Our new mouse model is suitable to further address the
role of Ncr1+ cell-derived IFN-γ also in other models of infection, as well as of autoimmu-
nity and cancer.
Introduction
Upon viral infection, interferons play a crucial role in host protection. While type I interferons
(IFN-I) primarily confer early anti-viral effects, type II interferon (IFN-γ) additionally activates
myeloid cells, and induces Th1 driven adaptive immunity [1, 2]. IFN-γ is expressed by innate
immune cells such as NK cells as well as by adaptive immune cells such as T cells. NK cells rap-
idly react to viral infections by lysing infected cells directly in an antigen-independent manner
and by producing cytokines such as IFN-γ until the adaptive immune system is sufficiently
activated to control the infection [3–9]. Also stimulated CD4+ and CD8+ T cells produce IFN-
γ and they are of key relevance for the induction of long-term memory responses. So far, the
role of innate and adaptive immune cell-derived IFN-γ expression was addressed by selective
depletion of specific cell subsets or by adoptive transfer experiments [10–15]. However, the
Ncr1-specific IFN-γ expression during VACV infection
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particular role of innate immune cell-derived IFN-γ expression has not yet been addressed
specifically.
Live vaccinia virus (VACV) vaccination was successfully used to eradicate the infectious
agent of the human smallpox disease, variola virus [16]. VACV has been extensively used as a
model to study the induction and effector mechanisms of early innate as well as adaptive
immunity. Upon VACV infection, IFN-γ deficient (IFN-γ-/-) and IFN-γ receptor deficient
(IFN-γR-/-) mice show enhanced susceptibility to lethal disease [17, 18]. VACV infection
induces early IFN-I responses [19], which activate myeloid cells to produce cytokines such as
IL-15 and IL-12/IL-18 that subsequently activate NK cells [10, 20–24]. Activated NK cells are
essential to control VACV replication and are capable to produce IFN-γ [21, 23, 25, 26]. Early
IFN-γ production may then induce MHC-II expression on antigen presenting cells (APC),
which is crucial for CD4+ T cell activation [27–29]. So far, there have been inconsistent data
on the importance of CD4+ T-cell help during VACV infection [11–13]. Nevertheless, adaptive
immune responses are needed to control VACV infection since VACV infected RAG-/- mice
are rescued by adoptive transfer of IFN-γ producing CD8+ T cells [14, 15, 18, 25, 30]. Further
dissection of the role of innate immune cell-derived IFN-γ expression during the initial phase
of viral infections is needed for the development of new vaccination strategies that induce pro-
tective immunity.
To specifically analyze the role of early innate immune cell-derived IFN-γ expression dur-
ing viral infection, we generated conditional IFN-γOFF mice, in which the IFN-γ gene function
is disrupted and can be reconstituted in a Cre-dependent manner. We intercrossed IFN-γOFF
mice with Nrc1-Cre+/- mice, expressing Cre mainly in NK cells, and CD4-Cre+/- mice, express-
ing Cre mainly in T cells. Our results verified earlier observations that Nrc1-Cre showed highly
cell type selective Cre expression, whereas CD4-Cre mice showed Cre expression also in other
cell subsets than T cells and therefore were not optimally suited for Cre-dependent gene recon-
stitution approaches. Interestingly, in IFN-γNcr1-ON mice the cell sective IFN-γ gene reconsti-
tution was sufficient to balance cytokine responses, induce myeloid cell accumulation, control
viral replication, and to clear the VACV infection.
Results
Mice with a Ncr1-specific reconstitution of the IFN-γ gene function survive
VACV infection
To address the function of innate immune cell-derived IFN-γ, we generated IFN-γOFF mice
that carry a floxed gene trapping cassette (TRAP) in the first intron of the IFN-γ gene and thus
lack IFN-γ expression (for schematic depiction see Fig 1A). To selectively reconstitute the
IFN-γ gene function in T cells or NK cells, we planned to intercross IFN-γOFF mice with
CD4-Cre mice that show Cre expression primarily in T cells ([31], IFN-γCD4-ON mice) or
Ncr1-Cre mice that show NK cell-specific Cre expression ([32], IFN-γNcr1-ON mice), respec-
tively. To test the cell subset-specificity of the Cre expression first, we intercrossed CD4-Cre
and Ncr1-Cre mice with Rosa26RFP reporter mice and determined RFP expression in various
cell subsets as a measure of Cre-mediated recombination by flow cytometry. Of note, in
CD4-Cre+Rosa26RFP mice RFP expression was detected primarily in T cells, but to a minor
extent also in certain innate immune cell subsets such as NK cells, some of which may express
CD4 (Fig 1B). In contrast, in Ncr1-Cre+Rosa26RFP mice more than 50% of conventional
Nk1.1+Ncr1+ NK cells, which are also classified as Ncr1+ ILC1 [33, 34], showed RFP expres-
sion (Fig 1C). Of note, amongst non-NK ILC1, which represent a very rare cell subset within
the liver, only 1-2% of the cells showed marginal RFP expression (S1 Fig).
Ncr1-specific IFN-γ expression during VACV infection
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Fig 1. Cell selectivity of Cre-mediated recombination using CD4-Cre and Ncr1-Cre mice. (A) Schematic depiction of
TRAP-mediated inactivation of IFN-γ and of Cre-mediated reconstitution of the Ifng gene function. (B) Splenocytes of
Ncr1-specific IFN-γ expression during VACV infection
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To next study the cell-selective reconstitution of the IFN-γ gene function, spleen cells were
in vitro treated with PMA/ionomycin and intracellular IFN-γ expression was determined by
flow cytometry analysis. Indeed, under such conditions splenocytes from WT mice showed
IFN-γ expression in T cells as well as in NK cells. Similarly, splenocytes from IFN-γCD4-ON
mice showed IFN-γ expression in T cells and NK cells at a similar level as detected in spleno-
cytes from WT animals (Fig 1D). In contrast, splenocytes from IFN-γOFF mice lacked intracel-
lular IFN-γ expression, whereas splenocytes from IFN-γNcr1-ON mice showed IFN-γ
expression only in NK cells, but not in T cells (Fig 1E). Thus, IFN-γNcr1-ON mice are suitable to
study the in vivo function of innate cell-derived IFN-γ responses. Since the group of NK cells
comprises various cell subsets, we further analyzed NK cell-specific IFN-γ gene reconstitution
in tissue-resident NK cells and conventional NK cells. To this end, lymphocytes were isolated
from liver of WT, IFN-γOFF, and IFN-γNcr1-ON mice and in vitro treated with PMA/ionomycin.
Interestingly, only conventional NK cells mounted IFN-γ responses in WT and IFN-γNcr1-ON
mice, while liver-resident NK cells barely expressed IFN-γ (S1 Fig).
As expected from previous studies with conventional IFN-γ-/- and IFN-γR-/- mice [17, 35],
under homeostatic conditions IFN-γOFF as well as IFN-γNcr1-ON mice showed an overall normal
immune cell distribution in the spleen (Fig 1F). To study whether upon viral infection CD4- or
Ncr1-specific IFN-γ gene reconstitution affects systemic IFN-γ levels, WT, IFN-γOFF, IFN-
γCD4-ON and IFN-γNcr1-ON mice were intravenously (i.v.) infected with 2 x 106 pfu vaccinia virus
(VACV), serum samples were drawn at the indicated time points, and IFN-γ protein levels were
determined by an ELISA method. In WT and IFN-γCD4-ON mice two waves of IFN-γ responses
were detected, peaking on day 1 and 4 post infection (dpi) (Fig 2A). In contrast, IFN-γOFF mice
lacked IFN-γ responses entirely (Fig 2A). Infected IFN-γNcr1-ON mice also mounted two waves
of IFN-γ, of which the first and the second one peaked on 1 and 3 dpi, respectively (Fig 2A).
The overall magnitude of these Ncr1+ cell-derived IFN-γ responses was reduced when com-
pared with WT mice on both days. This indicates that early after VACV infection (day 1 to 3)
IFN-γ responses are contributed to a large extent by Ncr1+ innate immune cells, whereas at
later time points IFN-γ is produced primarily by other cells such as T cells. Next, we analyzed
whether the IFN-γ gene reconstitution in Ncr1+ cells suffices to promote survival upon VACV
infection. Indeed, IFN-γNcr1-ON mice survived the infection as well as WT and IFN-γCD4-ON
mice without signs of severe disease, while IFN-γOFF mice succumbed to the infection within 5
days (Fig 2B). Furthermore, IFN-γNcr1-ON mice were able to control viral replication, while
IFN-γOFF mice showed highly elevated virus titers and succumbed to the infection (Fig 2C).
Selective IFN-γ reconstitution only in Ncr1+ cells is sufficient to restore
VACV-induced cytokine responses
To study the cellular source of innate IFN-γ in greater detail, WT, IFN-γOFF, and IFN-γNcr1-ON
mice were VACV infected, 1 and 4 dpi splenocytes were isolated, and intracellular IFN-γ
R26RFPOFF (white) and R26RFPCD4-ON mice (black) were isolated and immune cell subsets were analyzed by flow cytometry
for RFP expression (n = 3, N = 1), one-tailed Mann-Whitney U test. (C) Splenocytes of R26RFPOFF (white) and R26RFPNcr1-ON
mice (black) were isolated and T and NK cells were analyzed by flow cytometry for RFP expression (n� 3, N = 2), one-tailed
Mann-Whitney U test. (D) Splenocytes were isolated from WT, IFN-γOFF and IFN-γCD4-ON mice, stimulated with PMA/
ionomycin for 4 h, and then analyzed by flow cytometry (n� 3, N = 2), paired T-test. Percentage of IFN-γ expressing T or NK
cells is shown. Error bars indicate mean ± SEM; ���p� 0.001. (E) Splenocytes were isolated from WT, IFN-γOFF and IFN-
γNcr1-ON mice, stimulated with PMA/ionomycin for 4 h, and then analyzed by flow cytometry (n� 3, N = 1–3), paired T-test.
Percentage of IFN-γ expressing T or NK cells is shown. Error bars indicate mean ± SEM; ���p� 0.001. (F) Immune cells were
isolated from naïve WT, IFN-γOFF and IFN-γNcr1-ON mice and total numbers of T cells, B cells, macrophages, and
polymorphonuclear neutrophils (PMN) in spleen was analyzed by FACS (n� 9, N = 3), one-tailed Mann-Whitney U test.
https://doi.org/10.1371/journal.ppat.1008279.g001
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expression was analyzed by flow-cytometry in NK cells and T cells. Ex vivo isolated splenic NK
cells of infected WT and IFN-γNcr1-ON mice showed spontaneous intracellular IFN-γ expres-
sion, while in NK cells of IFN-γOFF mice no IFN-γ expression was detected (Fig 3A and 3B).
Of note, 4 dpi IFN-γ expression was not detected in NK cells, irrespective of whether spleno-
cytes from WT, IFN-γOFF, or IFN-γNcr1-ON mice were analyzed (Fig 3A and 3B). One dpi re-
stimulated T cells lacked IFN-γ expression, irrespective of the genotype of the mice analyzed
(Fig 3A and 3B). In contrast, 4 dpi only re-stimulated T cells from WT mice showed IFN-γ
expression, while T cells from IFN-γOFF and IFN-γNcr1-ON mice did not (Fig 3A and 3B).
These results support the hypothesis that upon VACV infection early IFN-γ responses are con-
ferred by Ncr1+ innate immune cells, while 4 dpi other cells, such as T cells, contribute to IFN-
γ production.
To study effects of innate immune/NK cell-derived IFN-γ responses on the overall chemo-
kine and cytokine milieu, serum of VACV infected WT, IFN-γOFF, and IFN-γNcr1-ON mice was
analyzed 1 dpi, which is the peak of NK cell-derived IFN-γ responses, and at day 5, which is
the terminal time point of IFN-γOFF mice, by a multiplex cytokine array. Already 1 dpi,
enhanced cytokine levels were detected in the serum of infected WT mice, including IL-12p70,
IL-18, and IL-6, which are known to be produced mainly by myeloid cells. Furthermore, che-
mokines, which regulate myeloid cells, such as MCP-1, MCP-3 and CXCL5 were induced (Fig
3C). By 5 dpi, the inflammatory cytokine response was already reduced in WT mice. Interest-
ingly, in infected IFN-γOFF mice the overall cytokine milieu differed extensively from that of
infected WT mice. Specifically, IL-18 and CXCL5 levels were decreased, while IL-12p70 was
increased 1 dpi when compared with WT mice. On day 5 post infection the Th2 cytokine IL-5
and the pro-inflammatory cytokine IL-6 were massively upregulated in IFN-γOFF mice as well
Fig 2. IFN-γNcr1-ON mice are protected against lethal VACV infection. WT, IFN-γOFF, IFN-γCD4-ON and IFN-γNcr1-ON mice were i.v. infected with 2 x 106 pfu VACV.
(A) Serum samples were drawn at the indicated time points and analyzed for the IFN-γ content by an ELISA method (n = 6, N = 2); one-way Anova. (B) Survival was
monitored and in case body weight decrease by more than 20% of the initial bodyweight, or when the overall health status was dramatically reduced, mice were
sacrificed (n� 10, N = 3); Mantel Cox test. (C) Virus loads in ovaries was determined 5 days post infection (dpi) by plaque assay (n� 5, N = 2). Error bars indicate
mean ± SEM; ���p� 0.001, ��p� 0.01, �p� 0.05; one-tailed Mann-Whitney U test.
https://doi.org/10.1371/journal.ppat.1008279.g002
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as G-CSF and CCL-5 when compared with infected WT controls. In IFN-γNcr1-ON mice the
overall cytokine and chemokine profile was reminiscent of that of WT mice, while the overall
concentration of serum IFN-γ was reduced. Thus, IFN-γ expression by Ncr1+ cells is sufficient
to balance VACV-induced cytokine and chemokine responses.
IFN-γ expression of Ncr1+ cells regulates the distribution of peripheral
myeloid cell subsets
We next analyzed whether the early innate immune cell-derived IFN-γ affected the presence
and activation of myeloid cells on 4 dpi. VACV-infected WT mice showed significantly
increased percentages of polymorphonuclear neutrophils (PMN) in the blood 4 dpi when
compared with uninfected controls (Fig 4A). These effects were even more pronounced in
infected IFN-γOFF mice that had a significant increase of total numbers of PMN within the
blood, while in infected IFN-γNcr1-ON mice the percentages of PMN were comparable with
those in WT mice (Fig 4A). To investigate the influence of innate immune cell-derived IFN-γ
on the activation of myeloid cells within secondary lymphoid organs, we analyzed splenocytes
from VACV-infected mice. VACV-infected mice of the analyzed genotypes showed signifi-
cantly increased percentages as well as enhanced total counts of PMN in the spleen when com-
pared with uninfected controls (Fig 4B). In contrast, the percentages of macrophages
decreased in the spleen of WT and IFN-γNcr1-ON mice when compared with uninfected con-
trols, while in IFN-γOFF mice the percentages of macrophages were unaffected (Fig 4C). Of
note, upon infection total cell numbers of macrophages remained stable in all analyzed mice
(Fig 4C). These data indicate that IFN-γ expression only by Ncr1+ cells can affect PMN num-
bers in blood and spleen. Of note, in VACV-infected IFN-γOFF mice MHC-II expression on
macrophages was significantly downregulated, while macrophages from WT and IFN-
γNcr1-ON mice showed comparable MHC-II expression (Fig 4D). Thus, upon VACV infection
IFN-γ expression by Ncr1+ cells is sufficient to confer protection. Moreover, IFN-γ responses
of Ncr1+ cells modulate macrophage activation and myeloid cell function.
Discussion
VACV encodes several modulators of host immunity, including the viral soluble IFN-γ recep-
tor B8 and inhibitors of STAT-1 signaling, such as the viral phosphatase H1 and VH1 [36–38].
Nevertheless, the IFN-γ axis is still critically needed in order to protect mice against lethal
VACV infection [17, 18]. Here we focused on the analysis of IFN-γ that is expressed by innate
immune cells during homeostasis and VACV infection. To this end, we generated conditional
IFN-γOFF mice in which the IFN-γ gene function can be reconstituted in a Cre-dependent
manner. By intercrossing such IFN-γOFF mice with CD4-Cre we obtained IFN-γCD4-ON mice
in which the IFN-γ gene function was reconstituted primarily in T cells, but also to a lesser
extent in some other cell subsets. The issue of cell type-specific gene targeting in Cre mice,
including CD4-Cre mice, has recently been addressed inter alia in letters by Reizis and Becher
[39, 40]. Correspondingly, CD4-Cre mice are not suitable to reconstitute Ifng gene function
specifically in T cells and therefore experiments with IFN-γCD4-ON mice are not appropriate to
further dissect the contribution of IFN-γ responses of different cell subsets. In contrast, IFN-
Fig 3. Balanced cytokine responses in VACV infected IFN-γNcr1-ON mice. WT, IFN-γOFF and IFN-γNcr1-ON mice were i.v.
infected with 2 x 106 pfu VACV. (A/B) Splenocytes of infected mice were isolated 1 and 4 dpi, in vitro stimulated with CD3/
CD28 beads for 4 h and then analyzed by flow cytometry for IFN-γ expressing NK or T cells (n� 10, N = 3); one-tailed
Mann-Whitney U test. Error bars indicate mean ± SEM; ���p� 0.001, ��p� 0.01, �p� 0.05. (C) Serum samples were drawn
at the indicated time points and analyzed with a multiplex cytokine and chemokine array (n = 3, N = 1).
https://doi.org/10.1371/journal.ppat.1008279.g003
Ncr1-specific IFN-γ expression during VACV infection
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Fig 4. Normalized distribution of peripheral myeloid cell subsets in VACV infected IFN-γNcr1-ON mice. WT, IFN-γOFF and IFN-γNcr1-ON mice were i.v. infected
with 2 x 106 pfu VACV. At the indicated time points blood samples were drawn, spleen was prepared and myeloid cells were analyzed by flow cytometry (n� 7, N = 3).
(A) Percentages and total cell numbers of polymorphonuclear neutrophils (PMN) in the blood. Percentages and total cell numbers of (B) PMN or (C) macrophages in
spleen (pregated on CD3-, CD19- cells). (D) Percentages of MHC-II expressing macrophages in the spleen.
https://doi.org/10.1371/journal.ppat.1008279.g004
Ncr1-specific IFN-γ expression during VACV infection
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γNcr1-ON mice that show IFN-γ expression in innate immune cells such as NK cells were as
resistant to VACV infection as WT controls, whereas Cre-negative littermates succumbed to
the infection with similar kinetics as IFN-γ-/- mice. These data indicate that early IFN-γ
responses by Ncr1+ cells are sufficient to establish an anti-viral cytokine milieu, to balance
myeloid cell numbers, to control viral replication, and to promote the induction of an overall
protective immune response, even when the IFN-γ gene reconstitution efficacy is below 100%.
Previous studies with mice lacking either IFN-γ or the IFN-γ receptor revealed the critical
role of the IFN-γ axis during VACV infection [17, 18]. Moreover, a vast array of genetically
modified mice lacking either NK cells, T cells, or other cell subsets, which consequently were
also devoid of the corresponding effector functions, including IFN-γ and perforin, showed
enhanced susceptibility to VACV infection [10–15]. More recent studies showed that IFN-γ-/-
mice were protected against lethal VACV infection upon adoptive transfer of IFN-γ competent
CD8+ T cells, highlighting the critical role of T cell-derived IFN-γ during VACV infection
[18]. Nevertheless, the physiological role of the IFN-γ responses derived from innate immune
cells was not well understood, yet. Adoptive transfer experiments are generally informative,
but sometimes they are difficult to interpret due to (i) the manipulation of the cell subsets of
interest during the purification procedure, (ii) potentially non-physiological homing proper-
ties of adoptively transferred cell subsets, and (iii) very low numbers of transferred cells hom-
ing to the relevant sites. Therefore, we adapted a genetic approach in which the endogenous
Ifng gene function can be cell-selectively reconstituted upon Cre expression. To this end, by
homologous recombination we introduced a loxP flanked translational and transcriptional
stop (TRAP) cassette into the first intron of the IFN-γ gene of embryonic stem cells. Following
Cre mediated deletion of the TRAP cassette the gene function is reconstituted without leaving
a residual loxP site in the promoter region. Upon in vitro stimulation, splenocytes from IFN-
γNcr1-ON mice showed IFN-γ expression primarily in NK cells, while WT mice showed IFN-γ
expression in NK and T cells.
Similar to WT mice, also VACV-infected IFN-γNcr1-ON mice showed two waves of IFN-γ
expression in the serum. The first wave was moderately reduced and the IFN-γ peak on 4 dpi
was completely absent. Nevertheless, such mice survived VACV infection. These results indi-
cated that to a large extent also Ncr1+ cells contribute to early IFN-γ, whereas they produce
IFN-γ only in the beginning of the second wave, and still confer protection from VACV infec-
tion. ILCs, NKT cells, and γδ T cells also have been reported to express IFN-γ early during
viral infection and therefore could additionally contribute to the first wave of IFN-γ expres-
sion. Amongst ILC, ILC1 and ILC3 can express Ncr1 and are able to produce IFN-γ [41].
Importantly, ILC3 are primarily localized in gut mucosa and interact with microbiota. In con-
trast, ILC1 have previously been shown to include NK cells and to be involved in viral infec-
tions [42, 43]. We found that in IFN-γNcr1-ON mice more than 50% of conventional NK cells
show Ifng reconstitution, whereas non-NK ILC1 are very rare in the liver and show very low
levels of recombination. Formally, we cannot exclude that a minor subset of non-NK ILC1
showed IFN-γ reconstitution. Nevertheless, because non-NK ILC1 are a very minor cell subset,
in VACV infected IFN-γNcr1-ON mice the amount of IFN-γ contributed by non-NK ILC1 at
best can be only very marginal when compared with the contribution of classical NK cells. Of
note, ex vivo isolated liver-resident NK cells showed significantly reduced IFN-γ expression
upon in vitro stimulation when compared with conventional NK cells.
IFN-γ is known to regulate the magnitude and composition of cytokine and chemokine
responses [44]. Therefore, it was surprising that IFN-γ reconstitution in Ncr1+ cells sufficed to
induce a sustained anti-viral cytokine milieu following VACV infection. Upon VACV infec-
tion of IFN-γOFF mice the cytokines IL-12p70 and IL-18 that activate NK cells to produce IFN-
γ were deregulated, i.e., IL-12p70 was enhanced and IL-18 was reduced when compared with
Ncr1-specific IFN-γ expression during VACV infection
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WT controls. IFN-γOFF mice also showed increased G-CSF serum levels and accordingly
enhanced numbers of granulocytes in the periphery. This is in accordance with other studies
showing that granulocyte egress from the BM is induced by G-CSF, which in turn is inhibited
by IFN-γ [45, 46]. Furthermore, it was shown that PMN development is prevented by IFN-γ
[45, 47, 48]. In accordance, in VACV infected WT mice that mount systemic IFN-γ expression,
we observed a reduced abundance of PMN in blood, when compared with VACV infected
IFN-γOFF mice. Thus, NK cell-derived IFN-γ contributes to modulate PMN immunity.
It was discovered earlier that NK cells need to be in close proximity to, or even in direct
contact with, myeloid cells in order to get activated and to mount IFN-γ responses that in turn
shape myeloid cell function [49–53]. This model is supported by our data, showing that NK
cell-derived IFN-γ is necessary to prevent the earlier published capacity of VACV to downre-
gulate MHC-II expression on macrophages [54–56]. Previous studies already indicated that T
cells were major producers of the second IFN-γ wave after VACV infection and that the pres-
ence of IFN-γ expressing CD8+ T cells was of key relevance to control the infection [15, 18,
57]. Nevertheless, we found that Ncr1-specific reconstitution of the IFN-γ gene function was
sufficient to confer activation of the myeloid cell compartment upon VACV infection and to
control the infection.
IFN-γ has broad modulatory effects on immune as well as non-immune cells [58]. Interest-
ingly, excessive NK cell responses may impair adaptive immunity and attenuate the induction
of memory responses, e.g. after vaccination or during chronic infection [59–65]. On the other
hand, patients with NK cell deficiencies or deficiencies in the IFN-γ axis are predisposed to
severe, recurrent mycobacterial as well as viral infections [66–69]. Sepsis can induce severe
and fatal immunoparalysis in patients. IFN-γ can restore leucocyte function in such patients
by reversing sepsis-induced defects in glycolysis and oxidative metabolism [70–72]. Further-
more, several previous reports highlighted the possibility to use IFN-γ as an adjuvant in vacci-
nation approaches [73–75], and NK cells have been implicated to play a critical role early after
stem cell transplantation [76–78]. Finally, NK cells can also be effectors in acquired immunity
[79–81]. Thus, NK cell-mediated immunity and the IFN-γ axis are interesting targets that
need to be better understood for exploitation in clinical applications. We found that the induc-
tion of early IFN-γ expression by Ncr1+ cells is critical for eliciting fully effective immune
responses against VACV infection. These findings clearly demonstrate the underestimated
importance of NK cell-derived IFN-γ and give rise to new concepts on how protective immu-
nity is shaped.
Material and methods
Ethics statement
All animals were handled in compliance with regulations of the German Animal protection
law (Tierschutzgesetz). Experiments were approved by the Niedersa¨chsisches Landesamt fu¨r
Verbraucherschutz und Lebensmittelsicherheit (LAVES, Oldenburg, Germany, Grant number
33.12-42502-04-13/1072).
Mice and viruses
C57BL/6 (WT) (Harlan Winkelmann), B6.FVB-Tg(EIIa-cre)C5379Lmgd (EIIa-Cre-/+) [82],
B6.Tg(Ncr1-icre)265Sxl (Ncr1-Cre-/+) [32], B6.Tg(CD4-cre)1Cwi (CD4-Cre-/+) [31], Gt
(ROSA)26Sortm1Hjf (R26RFPOFF) mice [83], and B6.129P2-Ifngtm1Uka (IFN-γOFF) mice were
bred under specific pathogen free conditions at the central animal facility of TWINCORE and
the Helmholtz Center for Infection Research (HZI), Brunswick, Germany. Mouse experimen-
tal work was carried out using 8 to 12 week old mice in compliance with regulations of the
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German animal protection law. The VACV strain Western Reserve (originally provided by
Bernard Moss, NIH, Bethesda, MD) was propagated on BHK-21 cells (ATCC CCL-10). Virus
stocks were purified by sucrose density gradient ultracentrifugation. To determine virus loads,
organ homogenates were titrated on RK13 cells (ATCC CCL-37). Organ homogenates were
added to a confluent cell layer and overlaid with methylcellulose. Cell were incubated for 48
hours at 37˚C and plaque-forming units (pfu) per ml tissue were determined using crystal vio-
let staining. In all infection experiments mice were i.v. infected with 2 x 106 pfu VACV if not
otherwise indicated.
Generation of IFN-γNcr1-ON mice
For the generation of IFN-γOFF mice, a modified loxP flanked translational and transcriptional
gene trapping cassette (TRAP) [84, 85] encompassing a loxP flanked neo cassette was intro-
duced into the first intron of the IFN-γ gene of the E14 embryonic SV129/Ola stem cell, sub-
clone IB10 [86]. The TRAP cassette contained a strong engrailed 2 splice acceptor that confers
a premature transcriptional stop of the IFN-γ gene, whereas following Cre mediated deletion
of the TRAP cassette the Ifng gene function is reconstituted with leaving a residual loxP site in
the first intron region. The genetically modified embryonic stem cells were microinjected into
BALB/c blastocysts and a chimeric founder was identified that upon mating with BALB/c
females passed the introduced mutation on to the next generation with the expected frequency.
In order to remove the neo cassette in vivo without also deleting the TRAP cassette, transgenic
offspring were intercrossed with EIIa-Cre mice that confer partial deletion of loxP flanked
DNA segments. Indeed, approximately 15% of the offspring showed deletion only of the neo
cassette, whereas the TRAP cassette was still present. These mice were back crossed for 4 gen-
erations on the C57BL/6 background (>99.6%). Offspring was further back crossed for two
more generations and mice with crossing over event in close proximity to the IFN-γ locus
(chromosome 10) were identified by using a short tandem repeat (STR) screening speed con-
genic approach (GVG Diagnostics). These IFN-γOFF mice were then intercrossed with
CD4-Cre+/- or Ncr1-Cre+/- mice in order to obtain IFN-γCD4-ON or IFN-γNcr1-ON mice,
respectively.
Genotyping
Genotyping was performed from ES cells or ear biopsies with primer pairs for floxed or wt
IFN-γ locus: IFN-γOFF (fwd 5’-TTTTGCCAGTTCCTCCAGAT-3’; rev 5’-GCTGGCCCTACT
CACACTTC-3’) and for IFN-γWT/ON (fwd 5’-TTTTGCCAGTTCCTCCAGAT-3’; rev 5’- TCA
GAGGCCTGGACCATAAG-3’).
Cytokine and chemokine analyses
Serum was tested for IFN-γ using the Ready-SET-Go! Kit (eBioscience), following the manu-
facturer’s instructions. Multiplex cytokine array was performed using the Bio-Plex Pro Mouse
Cytokine 23-Plex Assay (Bio-Rad), following the manufacturer’s instructions.
Cell isolation and flow cytometry
Splenocytes were filtered through 70 μm cell strainers and centrifuged at 300 g for 6 min at
4˚C. Myeloid cells from liver were prepared as described previously [19]. Following red blood
cell lysis (Sigma), cells were immunolabeled with fluorochrome-conjugated antibodies (S1
Table) (Biolegend and BD) for flow-cytometry analysis (LSR II Sorb, Becton Dickinson). Intra-
nuclear staining of ILC1 was performed using the Transcription Factor Buffer Set (BD
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Pharmingen). Blood was directly immunolabeled with fluorochrome-conjugated antibodies
(S1 Table) (Biolegend and BD) for flow-cytometry analysis (LSR II Sorb, Becton Dickinson)
and subsequently treated with red blood cell lysing solution (BD). The gating of different cell
populations is indicated in the supporting information section (S2 Fig). Cell counts were deter-
mined using AccuCheck counting beads (Life technology).
Stimulation of splenocytes and intracellular cytokine staining
Isolated splenocytes of naïve mice were stimulated with 10 ng/ml PMA and 1 μg/ml ionomy-
cin, splenocytes of VACV-infected mice were re-stimulated with CD3/CD28 T cell activation
beads or left untreated for 4 hours in the presence of Golgi-Block (BD). Cells were immunola-
beled with fluorochrome-conjugated antibodies (Biolegend and BD, see S1 Table) and subse-
quently stained with an intracellular cytokine kit (BD) for flow-cytometry analysis (LSR II
Sorb, Becton Dickinson).
Statistical analysis
Statistical analyses were performed using GraphPad Prism 6 software. Heatmaps were gener-
ated from mean values of each parameter using Prism 7.
Supporting information
S1 Fig. Ncr1-specific targeting of ILC1 and IFN-γ production of conventional and
resident NK cells. (A) Lymphocytes were isolated from liver of R26RFPNcr1-ON mice and
analyzed by flow cytometry. Percentage of RFP+ cells of either Ncr1+NK1.1+ NK cells or
Lin-CD127+T-bet+Rorγt- ILC1 were determined (n = 2, N = 1). (B)/(C) Lymphocytes were iso-
lated from liver of WT, IFN-γOFF and IFN-γNcr1-ON mice, in vitro stimulated with PMA/iono-
mycin for 4 h, and then analyzed by flow cytometry. Percentage of IFN-γ+ cells of either
Ncr1+NK1.1+CD49b+ conventional NK cells or Ncr1+NK1.1+CD49a+ resident NK cells were
determined (n = 4, N = 2); paired T Test. Error bars indicate mean ± SEM; ���p� 0.001,
��p� 0.01, �p� 0.05.
(TIF)
S2 Fig. Gating strategy for the analysis of defined cell subsets. Cells from spleen or liver
were isolated as described. (A) Amongst CD3-CD19- negative cells and F4/80+ macrophages
and Ly6G+ polymorphonuclear neutrophils (PMN) were analyzed. (B) Amongst NK1.1- and
TCRγδ- cells, CD3+CD4+ T cells were analyzed. Amongst CD3-CD4- cells NK1.1+Ncr1+ NK
cells were analyzed. (C) ILC1 were defined as lineage-CD127+T-bet+RORγt- Ncr1+ cells.
(TIF)
S1 Table. List of antibodies used in this study with clones, fluorophores, and manufactur-
ers.
(XLSX)
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